Shares in Hsinchu, Taiwan headquartered Taiwan Semiconductor Manufacturing Co. Ltd saw a slight drop of 0.32%, ending Monday's trading session at $30.87. The stock recorded a trading volume of 3.52 million shares. The Company's shares have gained 3.59% in the last one month, 1.95% over the previous three months, and 7.37% since the start of this year. The stock is trading 3.49% and 9.86% above its 50-day and 200-day moving averages, respectively. Moreover, shares of Taiwan Semiconductor Manufacturing, which engages in the computer-aided design, manufacture, packaging, testing, sale, and marketing of integrated circuits, color filters, and other semiconductor devices, have a Relative Strength Index (RSI) of 58.08. Visit us today and download your complete report on TSM for free at:
Hamilton, Bermuda headquartered Marvell Technology Group Ltd's stock climbed 0.25%, closing the day at $15.76. A total volume of 5.17 million shares was traded, which was above their three months average volume of 4.91 million shares. The Company's shares have advanced 12.25% in the last month, 25.32% in the previous three months, and 13.63% on YTD basis. The stock is trading 9.26% above its 50-day moving average and 29.99% above its 200-day moving average. Additionally, shares of Marvell Technology Group, which designs, develops, and markets analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits, have an RSI of 71.47.
On January 17th, 2017, Marvell Technology announced that it was named to Clarivate Analytics' Top 100 Global Innovators list for the fifth consecutive year. The Company received the award for its deep culture of innovation and robust intellectual property achievements with more than 9,000 patents worldwide.
On February 06th, 2017, research firm Cowen reiterated its 'Outperform' rating on the Company's stock with an increase of the target price from $18 a share to $20 a share. The complimentary research report on MRVL can be accessed at:
On Monday, shares in San Jose, California headquartered InvenSense Inc. recorded a trading volume of 4.17 million shares, which was higher than their three months average volume of 3.49 million shares. The stock ended the day 3.33% lower at $11.92. The Company's shares have surged 63.74% over the previous three months. The stock is trading above its 50-day and 200-day moving averages by 6.31% and 48.07%, respectively. Furthermore, shares of InvenSense, which designs, develops, manufactures, markets, and sells sensor systems on a chip in the US, China, Taiwan, South Korea, Japan, France, Canada, Slovakia, and Italy, have an RSI of 49.34.
On January 05th, 2017, InvenSense announced that the InvenSense ICM-30632 Wearable Sensor System on Chip (SoC) is being used to deliver the wrist worn fitness/wellness features in children wristband products by Chinese OEM eeBBK. The new product launch of eeBBK's children's watch, is using InvenSense's wearable SoC to deliver a variety of sensor related wellness/fitness features such a Photoplethysmography Motion artifact correction, steps, activity classification, distance, and sleep analysis. Register for free on Stock-Callers.com and download the PDF research report on INVN at:
San Jose, California headquartered Xilinx Inc.'s stock rose 0.02%, finishing yesterday's session at $58.23 with a total trading volume of 1.35 million shares. The Company's shares have advanced 0.52% in the last one month and 15.63% in the previous three months. The stock is trading above its 50-day and 200-day moving averages by 1.19% and 13.97%, respectively. Additionally, shares of Xilinx, which designs and develops programmable devices and associated technologies worldwide, have an RSI of 51.87.
On January 18th, 2017, research firm Barclays downgraded the Company's stock rating from 'Equal Weight' to 'Underweight' while revising its previous target price from $48 a share to $53 a share.
On January 25th, 2017, Xilinx announced that Q3 FY17 sales of $586 million, up 1% sequentially, and up 3% from Q3 FY16. The Company's Q3 FY17 net income was $142 million, or $0.52 per diluted share, compared to net income of $131 million, or $0.49 per diluted share, for Q3 FY16. Xilinx's Board of Directors declared a quarterly cash dividend of $0.33 per outstanding share of common stock payable on February 23rd, 2017 to all stockholders of record at the close of business on February 08th, 2017. Get free access to your research report on XLNX at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA